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Abstract 
Recent studies implicate that apelin and its receptor APJ may have important role for the 
modulation of angiogenesis. The aim of this study was to further characterise the regulation 
of apelin/APJ system in bovine ovary. Experiment 1: corpora lutea (CL) were assigned to the 
following stages: days 1-2, 3-4, 5-7, 8-12, 13-16, >18 (after regression) of oestrous cycle and 
of gravidity (month <3, 3-5, 6-7 and >8). Experiment 2: Follicles during maturation were di-
vided into granulosa cells (GC) and theca interna (TI) and were examined separately. Classi-
fication of follicles occurred by follicle size and oestradiol-17β (E2) concentration in the fol-
licular fluid (FF) (<0.5 ng/ml, 0.5-5 ng/ml; 5-40 ng/ml; 40-180 ng/ml; >180 ng/ml). Real-time 
RT-PCR (qPCR) was applied to investigate mRNA expression of examined factors. In gen-
eral, the expression level of apelin during the oestrous cycle was significantly higher com-
pared to the one during pregnancy. Apelin mRNA levels were always high during the cycle 
with a tendency of decrease after CL regression. The APJ mRNA in the CL was significantly 
up regulated on days 5-7 and 8-12 followed by a decrease on days 13-16, and further on days 
>18. The expression of APJ does not show any significant regulation in the CL throughout 
pregnancy. The expression of apelin and APJ was not statistically regulated in GC, but was 
significantly up regulated in follicles with an E2 concentration of more than 5 ng/ml and 
showed an increase according to growth and maturation of follicles. In conclusion, our data 
suggest that apelin/APJ system is involved in the mechanism regulating angiogenesis during 
follicle maturation as well as during CL formation and function in the bovine ovary. 
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INTRODUCTION 
Apelin is a novel bioactive peptide and the en-
dogenous ligand for APJ, an angiotensin-1-like re-
ceptor. It recently has been isolated from the bovine 
stomach [1-3]. Before the isolation of apelin, the APJ 
receptor was referred to as an orphaned 
G-protein-coupled receptor because its endogenous 
ligand was unidentified. Rat, mouse, cow, and human 
apelin cDNA have yet been characterized [2-4]. The 
apelin peptide is produced through processing from 
the C-terminal portion in the pre-proprotein consist-
ing of 77 amino acid residues and exists in multiple 
molecular forms [5]. Subsequent studies have found 
that endogenous apelin exists in multiple molecular 
forms with different biological activities [6]. Apelin 
mRNA and immunoreactive apelin were detected in 
various tissues and organs such as stomach, brain, 
heart, lung, uterus and ovary [3-5,7]. Moreover, in 
rats, apelin is localized within the endothelia of small 
arteries in many organs such as liver, spleen, lung, 
pancreas and adipose tissues [8,9]. It is already pos-
tulated that the apelin signalling pathway plays a role 
in the central and peripheral regulation of the car-Int. J. Biol. Sci. 2009, 5 
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diovascular system, such as blood pressure and blood 
flow [5], in water and food intake, and possibly in 
immune function [6]. What is more, detailed evalua-
tion of APJ and apelin expression patterns in em-
bryogenesis, and in the developing retina, suggested 
the hypothesis that autocrine signalling of this path-
way in endothelial cells (EC) provides a mechanism 
for regulating new blood vessel growth, or angio-
genesis [10,11]. Activation of this pathway in cultured 
EC has been shown to promote migration and prolif-
eration, and blood vessel growth–promoting func-
tions of apelin have been demonstrated in the Ma-
trigel plug assay in the mouse and chick chorioallan-
toic membrane assay [11]. 
Besides hormonal effects, angiogenesis, changes 
in blood flow and extra cellular matrix remodelling 
are important processes which are associated with the 
development, function and regression of the bovine 
corpus luteum (CL) [7]. The bovine CL is a transient 
organ that secretes progesterone (P4), a prerequisite 
for the establishment and maintenance of pregnancy 
[7]. The CL undergoes drastic changes in its function 
and structure during the oestrous cycle. Active an-
giogenesis is necessary for the fast growth of the CL. 
Therefore angiogenesis and P4 synthesis occur during 
CL development and are kept up during maintenance 
of CL function. Furthermore locally produced growth 
factors may have important modulator roles in final 
ovarian follicular growth. In cattle, ovarian follicular 
development is characterised by two or three con-
secutive follicular waves per oestrous cycle [12,13]. 
Each wave involves the recruitment of a cohort of 
follicles and the selection of a dominant follicle, which 
continues to grow and mature to the preovulatory 
stage while others in the wave undergo atresia. A 
complex regulatory system must exist to determine 
which follicles are selected [14]. That angiogenesis, the 
formation of new capillaries to a dense network, may 
play an important role in the selection process was 
suggested by previous studies that demonstrated that 
the selected follicle possesses a more elaborate mi-
crovasculature than other follicles [15]. The participa-
tion of angiogenic factors, for instance vascular en-
dothelial growth factor (VEGF) and basic fibroblast 
growth factor (FGF2) in bovine follicles during final 
growth was aim of several investigation in the past 
[7,14,16] and Kidoya et al. [17] have recently shown in 
vitro, VEGF and FGF increase APJ and apelin expres-
sion in endothelial cells (EC) respectively. 
Given their role in angiogenesis apelin and its 
receptor APJ are hypothesized to be involved in CL 
formation, function and regression during oestrus 
cycle and gravidity and in maturation and selection of 
developing follicles. Therefore, in the present study, 
local mRNA expression and the possible role o the 
apelin/APJ system in the bovine ovary was examined 
by q-RT-PCR. 
MATERIAL AND METHODS 
Experiment 1: Collection of CL during the oestrous cycle 
and pregnancy 
The CL of the cows were collected at the local 
slaughterhouse within 10-20 min of slaughter. The 
stage of oestrous cycle was determined by examining 
macroscopically the size, colour, consistency, connec-
tive tissue and mucus of the ovaries and uteri as pre-
viously described [18]. CL were assigned to the fol-
lowing stages; days 1-2, 3-4, 5-7, 8-12, 13-16, >18 (after 
regression) of oestrous cycle and of pregnancy; month 
1-2, 3-4, 6-7, >8 (the crown-rump length of the fetus 
was measured to evaluate the month of pregnancy). 
Luteal tissue was frozen in liquid nitrogen and stored 
at -80°C until RNA extraction. 
Experiment 2: Collection of follicles during final follicular 
growth  
Entire reproductive tracts from cows were col-
lected at a local slaughterhouse within 10–20 min after 
slaughter and were transported on ice to the labora-
tory. The stage of the oestrous cycle was defined by 
macroscopic observation of the ovaries (color, consis-
tency, corpus luteum stage, number and size of folli-
cles) and the uterus (color, consistency and mucus). 
Only follicles which appeared healthy (i.e. well vas-
cularized and having transparent follicular wall and 
fluid) and whose diameter was >5 mm were used. 
Large follicles (>14 mm) were collected only after CL 
regression, with signs of mucus production in the 
uterus and cervix and were assumed to be preovula-
tory. For the RNA extraction the follicles were dis-
sected from the ovary. The surrounding tissue (theca 
externa) was removed with forceps under a stereo 
microscope as previously described [19]. After aspi-
ration of FF, the follicles were bisected and their in-
side wall was gently scraped and flushed with 
Ringer’s solution (Fresenius, Wendel, Germany) to 
remove the granulosa cells (GC). The GC in the FF as 
well as in the flushing solution were centrifuged at 
2000 g for 10 min at 4°C. The theca interna tissue (TI) 
and GC pellet were snap frozen in liquid nitrogen and 
stored at -80°C until RNA isolation. The FF was stored 
at -20°C until determination of P4 and E2. 
Since healthy follicles have relatively constant P4 
levels in FF, only follicles with P4 below 100 ng/ml FF 
were used for the evaluation, to exclude atretic folli-
cles. The follicles were classified according to the E2 Int. J. Biol. Sci. 2009, 5 
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content in FF as follows; (i) <0·5; (ii) 0·5–5; (iii) 5–40; 
(iv) 40–180; and (v) >180 ng/ml FF. The correspond-
ing size of follicles were in the range of (i) 5–7 mm; (ii) 
8–10 mm; (iii) 10–13 mm; (iv) 12–14 mm and (v) >14 
mm. 
Hormone determination 
C o n c e n t r a t i o n s  o f  P 4  a n d  E 2  w e r e  d e t e r m i n e d  
directly in the FF with an enzyme immunoassay using 
the second antibody technique [20,21]. We used as 
enzyme solution progesterone-6β-hydroxy-hemisucci 
nate-horseradish Peroxidase (HRP) or oestra-
diol-17β-6-carboxy-methyloxim-HRP. Each poly-
clonal antibody was raised in a rabbit against pro-
gesterone-7α-carboxyethylthioether-BSA or for E2 
against oestradiol-17β-6-carboxymethyloxim-BSA. 
The effective dose for 50% inhibition (ED50) of the 
assay was 6 ng/ml for P4 and 3.5 pg/ml for E2. The 
FF was diluted accordingly. The intraassay variations 
were 4–5% (P4) and 6–7% (E2) and the interassay 
variations 8–9% (P4) and 9–10% (E2) [14].  
Total RNA extraction and quality determination 
Small Slices of deep frozen (-80°C) CL and folli-
cle cells were cut and weighted. Total RNA from the 
follicles and CL were isolated using the NucleoSpin 
RNA kit (Macherey-Nagel, Dueren, Germany). The 
RNA was dissolved in RNase-free water and spec-
troscopically quantified at 260 nm. Aliquots were 
subjected to 1% denaturing agarose gel electrophore-
sis and ethidium bromide staining to verify the quan-
tity and quality of RNA. 
The purity of RNA was verified by optical den-
sity (OD) absorption ratio OD260 nm/OD280 nm 
between 1.8 and 2.0. Degradation of the RNA was 
measured with the Agilent 2100 Bioanalyzer (Agilent 
Technologies, Deutschland GmbH,Waldbronn, Ger-
many) in conjunction with the RNA 6000 Nano Assay 
according to the manufacturer´s instructions. The 
Bioanalyzer enables the standardisation of RNA 
quality control. RNA samples were electrophoreti-
cally separated on a microfabricated chip and subse-
quently detected with laser induced fluoresence in-
duction. Each chip contains an interconnected set of 
microchannels that is used for separation of nucleic 
acid fragments based on their size as they are driven 
through the chip electrophoretically. The RNA 6000 
ladder standard is used as a reference for data analy-
sis. The software compares the unknown samples to 
the ladder fragments to determine its concentration 
and to identify the ribosomal RNA peaks of the un-
known sample (Bioanalyzer service). The Bioanalyzer 
electropherogram of total RNA shows two distinct 
ribosomal peaks corresponding to either 18S and 28S 
for eukaryotic RNA and a relatively flat baseline be-
tween the 5S and 18S ribosomal peaks. The auto-
matically calculated RNA integrity number (RIN) 
allows classification of total RNA based on a num-
bering system from 1 to 10, with 1 being the most de-
graded profile and 10 being the most intact [22]. 
RNA Reverse Transcription 
Constant amounts of 1 mg of total RNA were 
reverse transcribed to cDNA using the following 
master mix: 26 µl Rnase-free water, 12 µl 5x Buffer 
(Promega, Mannheim, Germany), 3 µl Random Prim-
ers (50 mM) (Invitrogen, Carlsbad, Germany), 3 µl 
dNTPs (10 mM) (Fermentas, St. Leon-Rot, Germany) 
and 200 U of MMLV Reverse Transcriptase (Promega, 
Mannheim, Germany) according to the manufac-
turer’s instructions as previously described [14]. 
Primers 
The primers used for real-time PCR were as fol-
lows: apelin (106 bp) forward, 
5’-AAGGCACCATCCGATACCTG-3’ and reverse , 
5’-ATGGGACCCTTGTGGGAGA-3’; APJ (100 bp) 
forward, 5’-TCTGGGCCACCTACACCTAT-3’ and 
reverse , 5’-ACGCTGGCGTACATGTTG-3’ [7,23] and 
histone (232 bp) forward, 5’- 
ACTGCTACAAAAGCCGCTC-3’ and reverse, 
5’-ACTGCCTCCTGCAAAGCAC-3’ [24]. 
Quantitative RT-PCR 
A master mix of the following reaction compo-
nents was prepared: 6.4 µl water, 1.2 µl MgCl2 (4 
mM), 0.2 µl forward primer (0.2 mM), 0.2 µl reverse 
primer (0.2 mM), and 1.0 µl LightCycler Fast Start 
DNA Master SYBR Green I (Roche Diagnostics, 
Mannheim, Germany). The master mix (9 µl) was 
added to the strip tubes and 1 µl PCR template con-
taining 16.66 ng (CL) or 8.33 ng (GC and TI) reverse 
transcribed total RNA was added. The following 
general real-time PCR protocol was employed for all 
investigated factors: denaturation for 10 min at 95°C, 
40 cycles of a three segmented amplification and 
quantification program (denaturation for 10 sec at 
95°C, annealing for 10 sec at the primer specific tem-
perature, elongation for 15 sec at 72°C), a melting step 
by slow heating from 60 to 99°C with a rate of 
0.58°C/sec and continuous fluorescence measure-
ment, and a final cooling down to 40°C. Crossing 
point (cp) values were acquired by using the second 
derivative maximum method of the Rotor-Gene 6 
software (Corbett Research, Mortlake, Australia). 
Real-time PCR efficiencies were determined by am-
plification of a standardized dilution series, and 
slopes were calculated using Rotor-Gene 6 software Int. J. Biol. Sci. 2009, 5 
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(Corbett Research, Mortlake, Australia). The specific-
ity of the desired products in bovine CL was docu-
mented using a high resolution gel electrophoresis 
and analysis of the melting temperature, which is 
product specific.  
Statistical Analyses 
The statistical significance of differences in 
mRNA expressions of the examined factors was as-
sessed by one-way ANOVA followed by the 
Holm-Sidak as a multiple comparison test. Differ-
ences were considered significant if P<0.05. All ex-
perimental data are shown as 40 minus the mean of cp 
± SEM. 
RESULTS 
RNA Integrity 
RNA quality was assessed using the Agilent 
Bioanalyzer 2100. The RNA samples were examined 
randomly and showed good RNA quality with a 
mean RIN of 7.86 ± 0.31, which is perfectly suitable for 
PCR analysis. 
Gene expression analysis 
The mRNA expression of the housekeeping gene 
histone was not statistically regulated. Thus it is as-
sumed that equal amounts of mRNA were used in 
each sample. In order to obtain the mRNA expression 
differences, the cp (crossing points) was not sub-
tracted from a control group, but from the value 40, so 
that a high “40-cp” value indicated a high gene ex-
pression level and vice versa. 
The mRNA expression of apelin and APJ in bovine CL during 
luteal phase and pregnancy 
The expression of mRNA in CL tissue during the 
luteal phase and pregnancy is shown in Fig. 1. Apelin 
mRNA expression in early (days 1-7) and mid-luteal 
stages (days 8-12) maintained high levels and were 
statistically higher than during pregnancy (P<0.05). 
On days 13-16 a tendency of decrease could be ob-
served, that dropped even further during regression 
of CL (Fig.1A). The APJ receptor mRNA expression 
increased in early luteal stages to reach the highest 
level at mid-luteal phase (P<0.05), followed by a sig-
nificant decrease afterwards. There were no signifi-
cant regulations in APJ expression during pregnancy 
and mRNA levels were comparable to those in 
mid-luteal phase (Fig. 1B). 
 
Figure 1: Expression of mRNA of (A) apelin and (B) APJ in 
the CL of oestrus cycle and gravidity. Results are presented 
by 40 minus mean of crossing points (cp) ± SEM (n=6-7). 
Different superscripts denote statistically different values 
(P<0.05). 
 
The mRNA expression of apelin and APJ in follicles during 
finale follicular growth 
The changes in mRNA expression for apelin and 
APJ in TI and GC of growing follicles are shown in 
Fig. 2 and Fig. 3. Apelin expression in TI of follicles 
with an E2 concentration from 5 to >180 ng/ml were 
significantly up regulated (Fig. 2A). The mRNA ex-
pression of its receptor APJ also increased signifi-
cantly from the smallest follicles to those with in-
creased E2 concentrations over 5 ng/ml in their FF 
(Fig. 2B). Apelin as well as APJ expression in GC 
showed no statistically significant regulations. For 
apelin mRNA constant expression levels (Fig. 3A) and 
for APJ a slight decrease from small to matured folli-
cles could be observed (Fig. 3B). 
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Figure 2: Expression of mRNA of (A) apelin and (B) APJ 
in the theka interna (TI) in follicles of different stages of 
follicle development and maturation. Results are pre-
sented by 40 minus mean of crossing points (cp) ± SEM 
(n=7-12). Different superscripts denote statistically dif-
ferent values (P<0.05). Classification of follicles occurred 
by follicle size and oestradiol-17β concentration in the FF 
(<0.5 ng/ml, 0.5-5 ng/ml; 5-40 ng/ml; 40-180 ng/ml; >180 
ng/ml). 
 
Figure 3: Expression of mRNA of (A) apelin and (B) APJ 
in granulosa cells (GC) in follicles of different stages of 
follicle development and maturation. Results are pre-
sented by 40 minus mean of crossing points (cp) ± SEM 
(n=7-12). Classification of follicles occurred by follicle 
size and oestradiol-17β concentration in the FF (<0.5 
ng/ml, 0.5-5 ng/ml; 5-40 ng/ml; 40-180 ng/ml; >180 ng/ml). 
 
DISCUSSION 
Apelin and APJ have been investigated in many 
organs and tissues including the brain, heart, lung, 
kidney, uterus and ovary using PCR and immuno-
histochemistry [3-5, 25-27]. The objective of the pre-
sent study was to demonstrate the expression of ape-
lin and APJ in detail in bovine CL obtained from dif-
ferent stages of the oestrous cycle and during preg-
nancy - and to demonstrate that apelin and its recep-
tor are expressed clearly in bovine follicles during 
final growth to preovulatory follicles. We evaluated 
their expression in separated bovine GC and TI. 
After angiogenesis the CL becomes one of the 
most highly vascularized organs and receives the 
greatest rate of blood flow [28]. Our findings that 
apelin mRNA maintained high levels in early and 
mid-luteal stages, where angiogenesis takes place to 
ensure the fast growth of the CL and its supply are in 
coincidence with those of Shirasuna et al. [7]. Recent 
studies have shown the angiogenic effect of apelin 
when working cooperatively with the prominent an-
giogenic factors VEGF or FGF [29,31]. The presence of 
a localized source of apelin induced vascular devel-
opment and angiogenic branching whose effects were 
abolished in APJ-deficient frog embryos in vivo [11]. 
Moreover, it was shown that apelin can stimulate the 
proliferation and migration of EC in mouse [28]. Both, 
apelin and APJ showed a decline at the end of the 
luteal phase and dropped steeply during CL regres-
sion. At this point of time no angiogenesis is needed 
any more due to the beginning degradation of CL 
tissue and vessels [32]. The co-expression of mRNA of 
apelin and APJ strongly suggest that apelin may have 
some function as a local regulator in the bovine CL. Int. J. Biol. Sci. 2009, 5 
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Therefore, our findings suggest that the apelin/APJ 
system may be an autocrine and/or paracrine factor, 
and may have physiological roles in the vascular es-
tablishment, maturation, and maintenance mainly in 
the CL during oestrous cycle. The possible role during 
pregnancy is not strong convincing. For both, apelin 
and APJ mRNA expression an increase could be ob-
served in TI from growing follicles with increasing E2 
concentrations. The strong expression of apelin and its 
receptor APJ in the mature follicles raises the possi-
bility that these factors may play a role in angiogene-
sis that accompanies follicular growth and selection. 
Previous work in primate follicles has shown that the 
density of the microvascular network of the selected 
follicle is at least double that of follicles of lesser ma-
turity. This increased capillary density resulted in a 
greater delivery of gonadotropic hormones to the se-
lected follicle in vivo [15]. The process of follicle selec-
tion requires a mechanism by which a single follicle 
continues to survive in the presence of gonadotropin 
concentrations which are insufficient to support the 
growth of other follicles [29]. Our finding that apelin 
and APJ are expressed and strongly regulated in TI 
underline these assumptions, suggesting that the 
apelin/APJ system may act as a chemo attractant for 
sprouting endothelial cells. In addition, Shimizu et al. 
[ 2 3 ]  a l s o  r e p o r t e d  t h a t  A P J  i s  e x p r e s s e d  i n  b o v i n e  
granulosa cells, and progesterone stimulated the ex-
pression of APJ in granulosa cells. The expression of 
apelin and APJ in mature follicles suggests that the 
apelin/APJ system could play an important role 
during follicle selection and dominance in the cow.  
In conclusion, our results demonstrate the dis-
tinct up-regulation during development of bovine 
follicles of mRNA of the apelin/APJ system. The re-
sults are consistent with the hypothesis that these 
factors may have angiogenic effect and may be in-
volved in the proliferation of capillaries that accom-
panies the selection of the preovulatory follicle, re-
sulting in an increased supply of nutrients and pre-
cursors, and therefore supporting growth of the 
dominant follicle. Moreover apelin and APJ showed 
statistically regulated expression levels during CL 
formation and function. That led to the assumption 
that this system may be associated with vascular 
function in the bovine ovary. 
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